{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/ACUT"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"ACUT","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"ACUT\",,,,,undefined,":{"symbol":"ACUT","market":"US","secType":"STK","nameCN":"Accustem Sciences Inc.","latestPrice":0.634,"timestamp":1770411600000,"preClose":0.5709,"halted":0,"volume":658,"delay":15,"changeRate":0.11052723769486784,"floatShares":9922079,"shares":16072267,"eps":0,"marketStatus":"Market Closed","change":0.0631,"latestTime":"02-06 16:00:00 EST Delay","open":0.5709,"high":0.634,"low":0.5709,"amount":384.42220999999995,"amplitude":0.110527,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"otc":true,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1770627600000},"marketStatusCode":7,"adr":0,"exchange":"OTCQB","adjPreClose":0.5709,"volumeRatio":1.1885839653195043},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"ACUT\",,,,,undefined,":{"symbol":"ACUT","floatShares":9922079,"roa":"-120.29%","roe":"-1794.16%","lyrEps":0,"volumeRatio":1.1885839653195043,"shares":16072267,"dividePrice":0,"high":0.634,"amplitude":0.110527,"preClose":0.5709,"low":0.5709,"week52Low":0.2251,"pbRate":"-3.50","week52High":2.33,"institutionHeld":0,"latestPrice":0.634,"eps":0,"divideRate":0,"volume":658,"delay":15,"open":0.5709,"prevYearClose":0.81351,"prevWeekClose":0.6,"prevMonthClose":0.6,"prevQuarterClose":0.8135,"fiveDayClose":0.6,"twentyDayClose":0.7,"sixtyDayClose":0.847},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/ACUT\",params:#limit:5,,,undefined,":[{"market":"US","date":"2024-09-16","symbol":"ACUT","fiscalQuarterEnding":null,"expectedEps":null,"name":null,"time":"","type":"earning","dateTimestamp":1726459200000,"reportTimeType":"","actualEps":null},{"market":"US","date":"2024-05-20","symbol":"ACUT","fiscalQuarterEnding":null,"expectedEps":null,"name":null,"time":"","type":"earning","dateTimestamp":1716177600000,"reportTimeType":"","actualEps":null}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"ACUT\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"ACUT\",market:\"US\",delay:false,,,undefined,":{},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"ACUT\",pageSize:4,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2601366464","title":"AccuStem Sciences Partners with NSABP for StemPrintER Pilot Study","url":"https://stock-news.laohu8.com/highlight/detail?id=2601366464","media":"Reuters","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2601366464?lang=en_us&edition=fundamental","pubTime":"2026-01-08 20:00","pubTimestamp":1767873628,"startTime":"0","endTime":"0","summary":"AccuStem Sciences Ltd. has announced a partnership with the National Surgical Adjuvant Breast and Bowel Project  to conduct a pilot study evaluating the StemPrintER test in a subset of patients from the B-32 cohort. This collaboration aims to validate the predictive capabilities of StemPrintER, a diagnostic test that stratifies early stage breast cancer patients by recurrence risk based on tumor \"stemness.\" Positive results from this study could have significant implications for surgical planning and patient outcomes in breast cancer care.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Accustem Sciences Ltd. published the original content used to generate this news brief via GlobeNewswire  on January 08, 2026, and is solely responsible","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260108:nNDL2KXgK1:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SG9999014039.USD","SG9999014013.SGD","LU0314104364.USD","IE00B3QW5Z07.USD","LU2095319765.USD","SG9999014005.SGD","BK4588","IE00B64PRP62.GBP","LU2210150020.SGD","LU2210149790.SGD","SG9999014021.USD","IE00BGHQF748.EUR","NDAQ","BK4139","IE00BKPKM429.USD","ACUT","BK4585","BK4112"],"gpt_icon":0},{"id":"2586256260","title":"Accustem Sciences MSC Lung Cancer Test Enters Medicare Coverage Review Queue","url":"https://stock-news.laohu8.com/highlight/detail?id=2586256260","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2586256260?lang=en_us&edition=fundamental","pubTime":"2025-11-27 05:16","pubTimestamp":1764191800,"startTime":"0","endTime":"0","summary":"Accustem Sciences Ltd. has announced that its application for a local coverage determination for its MSC test has been accepted as complete and valid by Novitas Solutions, a Medicare Administrative Contractor for the Centers for Medicare & Medicaid Services  in the JL region. The application will now enter the regulatory review queue. The MSC test is a non-invasive blood-based assay designed to assess lung cancer risk in patients who qualify for screening or have indeterminate pulmonary nodules. No other organizations are mentioned as recipients of this review.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Accustem Sciences Ltd. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, A","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251126:nNDLpCPWp:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ACUT","BK4139"],"gpt_icon":0},{"id":"2568146072","title":"Accustem Sciences and Emeritusdx Expand Blood-Based Testing Capabilities to Advance Cancer Diagnostics and Treatment Planning","url":"https://stock-news.laohu8.com/highlight/detail?id=2568146072","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2568146072?lang=en_us&edition=fundamental","pubTime":"2025-09-17 19:00","pubTimestamp":1758106801,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250917:nTUA7709QB:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","ACUT"],"gpt_icon":0}],"pageSize":4,"totalPage":1,"pageCount":1,"totalSize":3,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/market/plate/belongs/ACUT\",params:#limit:6,delay:false,,,undefined,":[]}}